Characteristics of the 132 Human Immunodeficiency Virus-infected Study Participants
| Characteristic . | Uncomplicated Syphilis, n = 64 . | Neurosyphilis, n = 68 . | P-value . |
|---|---|---|---|
| Male | 63 (98.4) | 68 (100.0) | NS |
| Race | |||
| Black | 11 (17.2) | 9 (13.2) | NS |
| White | 47 (73.4) | 55 (80.9) | |
| Other | 6 (9.4) | 4 (5.9) | |
| Age | 37 (32–43) | 41 (33–48) | NS |
| 1/serum RPR titer | 64 (8–128) | 128 (64–512) | <.001 |
| On antiretrovirals | 41 (68.3), n = 60 | 27 (45.0), n = 60 | .01 |
| Peripheral blood CD4 T cells/uL within 90 days | 445 (227–627), n = 56 | 432 (303–567), n = 63 | NS |
| Plasma HIV RNA copies/mL within 90 days | 60 (50–4582), n = 57 | 10765 (50–92938), n = 64 | .006 |
| Previous AIDS diagnosis | 28 (43.8) | 25 (37.3), n = 67 | NS |
| Mental alternation test score <18 | 13 (21.0), n = 62 | 17 (25.0) | NS |
| Characteristic . | Uncomplicated Syphilis, n = 64 . | Neurosyphilis, n = 68 . | P-value . |
|---|---|---|---|
| Male | 63 (98.4) | 68 (100.0) | NS |
| Race | |||
| Black | 11 (17.2) | 9 (13.2) | NS |
| White | 47 (73.4) | 55 (80.9) | |
| Other | 6 (9.4) | 4 (5.9) | |
| Age | 37 (32–43) | 41 (33–48) | NS |
| 1/serum RPR titer | 64 (8–128) | 128 (64–512) | <.001 |
| On antiretrovirals | 41 (68.3), n = 60 | 27 (45.0), n = 60 | .01 |
| Peripheral blood CD4 T cells/uL within 90 days | 445 (227–627), n = 56 | 432 (303–567), n = 63 | NS |
| Plasma HIV RNA copies/mL within 90 days | 60 (50–4582), n = 57 | 10765 (50–92938), n = 64 | .006 |
| Previous AIDS diagnosis | 28 (43.8) | 25 (37.3), n = 67 | NS |
| Mental alternation test score <18 | 13 (21.0), n = 62 | 17 (25.0) | NS |
Results are expressed as n (%) or median (interquartile range).
Abbreviations: HIV, human immunodeficiency virus; NS, not significant; RPR, rapid plasma reagin.
Characteristics of the 132 Human Immunodeficiency Virus-infected Study Participants
| Characteristic . | Uncomplicated Syphilis, n = 64 . | Neurosyphilis, n = 68 . | P-value . |
|---|---|---|---|
| Male | 63 (98.4) | 68 (100.0) | NS |
| Race | |||
| Black | 11 (17.2) | 9 (13.2) | NS |
| White | 47 (73.4) | 55 (80.9) | |
| Other | 6 (9.4) | 4 (5.9) | |
| Age | 37 (32–43) | 41 (33–48) | NS |
| 1/serum RPR titer | 64 (8–128) | 128 (64–512) | <.001 |
| On antiretrovirals | 41 (68.3), n = 60 | 27 (45.0), n = 60 | .01 |
| Peripheral blood CD4 T cells/uL within 90 days | 445 (227–627), n = 56 | 432 (303–567), n = 63 | NS |
| Plasma HIV RNA copies/mL within 90 days | 60 (50–4582), n = 57 | 10765 (50–92938), n = 64 | .006 |
| Previous AIDS diagnosis | 28 (43.8) | 25 (37.3), n = 67 | NS |
| Mental alternation test score <18 | 13 (21.0), n = 62 | 17 (25.0) | NS |
| Characteristic . | Uncomplicated Syphilis, n = 64 . | Neurosyphilis, n = 68 . | P-value . |
|---|---|---|---|
| Male | 63 (98.4) | 68 (100.0) | NS |
| Race | |||
| Black | 11 (17.2) | 9 (13.2) | NS |
| White | 47 (73.4) | 55 (80.9) | |
| Other | 6 (9.4) | 4 (5.9) | |
| Age | 37 (32–43) | 41 (33–48) | NS |
| 1/serum RPR titer | 64 (8–128) | 128 (64–512) | <.001 |
| On antiretrovirals | 41 (68.3), n = 60 | 27 (45.0), n = 60 | .01 |
| Peripheral blood CD4 T cells/uL within 90 days | 445 (227–627), n = 56 | 432 (303–567), n = 63 | NS |
| Plasma HIV RNA copies/mL within 90 days | 60 (50–4582), n = 57 | 10765 (50–92938), n = 64 | .006 |
| Previous AIDS diagnosis | 28 (43.8) | 25 (37.3), n = 67 | NS |
| Mental alternation test score <18 | 13 (21.0), n = 62 | 17 (25.0) | NS |
Results are expressed as n (%) or median (interquartile range).
Abbreviations: HIV, human immunodeficiency virus; NS, not significant; RPR, rapid plasma reagin.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
